The conference welcomed the representatives of the ECE line departments, heads of executive authorities of the EEU states, medical communities and manufacturers to share and develop proposals on the enhancement of the industry promotion in the ECE.

Maksim Stetsyuk, Executive Director for NANOLEK, spoke at the conference on the role of bio-safety in pharmaceutical production. He noted that the issue of biosafety is not limited, therefore it is especially worthwhile creating updated approaches to preventive vaccination and ensure the availability of high-quality, including multicomponent, and well tolerated vaccines.

“There is a successful case in our brand portfolio where we could arrange, as soon as possible, the availability of inactivated polio vaccine in accordance with the needs of the state customer. This was managed thanks to the inclusion of the drug in the list of strategically valuable medicines 2010. For us, the factor to define the further project development is definitely aguarantee of long-term demand for the new products from the state authorities. By introducing the uniform rules for pharmaceuticals registration, we hope that Russia-manufactured vaccines will be demanded by customers from other EEU states as part of national immunization schemes. Welcome. We are open for collaboration,” Maksim added.